Tyson Venture, the venture capital arm of meat giant Tyson Foods, has recently made an investment in a food safety startup.
Named Clear Labs Inc., the company developed a next-generation sequencing (NGS) platform that supports high-volume testing for salmonella. The platform is said to be able to collect hundreds of millions of data points per analysis that can be used to learn everything about a pathogen in a single test. The solution shortens turnaround times of current methods to 24 hours as opposed to three-to-five days.
In the press release announcing the Tyson Venture investments, Clear Labs notes that the start-up was created to “enable major brands to capitalize on a new of food safety technologies by advancing DNA sequencing, bioinformatics, and robotics to create preventive food safety management systems.”
This is Tyson’s first investment in the food safety space.
In related news, Tyson Foods also said it has sold its stake in plant-based product company Beyond Meat, which recently went public. According to sources speaking to CNBC, relations between the two companies had become tense, particularly after Tyson’s CEO announced that the company plans to create its own plant-based protein products.